Tivic Health Collaborates With Fletcher Spaght to Develop Strategy for Cervical Vagus Nerve Stimulation Technology

MT Newswires Live09-17

Tivic Health Systems (TIVC) said Tuesday it has collaborated with Fletcher Spaght to further develop its commercial strategy for non-invasive cervical vagus nerve stimulation, or ncVNS.

Fletcher Spaght initially determined about 30 potential medical use cases for Tivic's ncVNS technology as it started a thorough market study of the technology using data from the health tech company's phase 1 trial.

Fletcher Spaght is working with Tivic's experts to find the best market entry point by talking to key doctors, patients and insurance providers, Tivic said.

Financial details of the collaboration weren't provided.

Shares of Tivic fell 3.4% in recent trading.

Price: 0.27, Change: -0.01, Percent Change: -3.40

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2468366102?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-17 23:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2468366102","market":"nz","top_or_hot":-1,"title":"Tivic Health Collaborates With Fletcher Spaght to Develop Strategy for Cervical Vagus Nerve Stimulation Technology","media":"MT Newswires Live","content":"<html><body><p> Tivic Health Systems (TIVC) said Tuesday it has collaborated with Fletcher Spaght to further develop its commercial strategy for non-invasive cervical vagus nerve stimulation, or ncVNS.</p><p>Fletcher Spaght initially determined about 30 potential medical use cases for Tivic's ncVNS technology as it started a thorough market study of the technology using data from the health tech company's phase 1 trial.</p><p>Fletcher Spaght is working with Tivic's experts to find the best market entry point by talking to key doctors, patients and insurance providers, Tivic said.</p><p>Financial details of the collaboration weren't provided.</p><p>Shares of Tivic fell 3.4% in recent trading.</p><p>Price: 0.27, Change: -0.01, Percent Change: -3.40</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tivic Health Collaborates With Fletcher Spaght to Develop Strategy for Cervical Vagus Nerve Stimulation Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTivic Health Collaborates With Fletcher Spaght to Develop Strategy for Cervical Vagus Nerve Stimulation Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-17 23:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tivic Health Systems (TIVC) said Tuesday it has collaborated with Fletcher Spaght to further develop its commercial strategy for non-invasive cervical vagus nerve stimulation, or ncVNS.Fletcher Spaght...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2468366102","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468366102","pubTimestamp":1726587447,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Tivic Health Systems  said Tuesday it has collaborated with Fletcher Spaght to further develop its commercial strategy for non-invasive cervical vagus nerve stimulation, or ncVNS.Fletcher Spaght initially determined about 30 potential medical use cases for Tivic's ncVNS technology as it started a thorough market study of the technology using data from the health tech company's phase 1 trial.Fletcher Spaght is working with Tivic's experts to find the best market entry point by talking to key doctors, patients and insurance providers, Tivic said.Financial details of the collaboration weren't provided.Shares of Tivic fell 3.4% in recent trading.Price: 0.27, Change: -0.01, Percent Change: -3.40","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","TIVC":"Tivic Health Systems, Inc."},"translate_title":"Tivic Health与Fletcher Spaght合作开发颈部迷走神经刺激技术策略","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TIVC":0.9},"content_text":"Tivic Health Systems (TIVC) said Tuesday it has collaborated with Fletcher Spaght to further develop its commercial strategy for non-invasive cervical vagus nerve stimulation, or ncVNS.Fletcher Spaght initially determined about 30 potential medical use cases for Tivic's ncVNS technology as it started a thorough market study of the technology using data from the health tech company's phase 1 trial.Fletcher Spaght is working with Tivic's experts to find the best market entry point by talking to key doctors, patients and insurance providers, Tivic said.Financial details of the collaboration weren't provided.Shares of Tivic fell 3.4% in recent trading.Price: 0.27, Change: -0.01, Percent Change: -3.40","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468366102"}